Fundz

Fundz Deep Dive

Everything you need to win Robert Hollingsworth — in one platform.

Who to reach, what to say, and why now on Robert Hollingsworth — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Robert Hollingsworth — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Protillion Biosciences Appoints Robert Hollingsworth As Chief Scientific Officer

PRIVATEMar 24, 2026•3 months ago

Position

Chief Scientific Officer

Company

Protillion Biosciences

Robert Hollingsworth
BurlingameOtherBiotechnologyHealth Care

Description

Protillion Biosciences announced the appointment of Robert Hollingsworth, PhD, as Chief Scientific Officer. With over 30 years of drug development experience, Dr. Hollingsworth will lead the advancement of Protillion's antibody discovery platform.

Company Information

Company

Protillion Biosciences

Location

1400 MARSTEN RD. STE. M

Burlingame, California, United States

About

Protillion Biosciences is a Stanford University spinout commercializing disruptive technology for therapeutic antibody and binder discovery. While current state-of-the-art antibody discovery and optimization techniques may take months of laborious laboratory procedures executed by highly-skilled practitioners, Protillion's high throughput instrumentation can characterize the binding affinity on the order of 1 million antibody variants in a 2-day automated run. Our unique approach enables the identification of better antibody candidates on an exponentially faster timeline. For more information, visit www.protillion.com.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Protillion Biosciences's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.